Surgical displacement of subretinal hemorrhage associated with acute myeloblastic Leukemia

AJO International Pub Date : 2024-04-24 DOI:10.1016/j.ajoint.2024.100017

Melis Kabaalioglu Guner, Kevin Ferenchak, Sophie J. Bakri

{"title":"Surgical displacement of subretinal hemorrhage associated with acute myeloblastic Leukemia","authors":"Melis Kabaalioglu Guner, Kevin Ferenchak, Sophie J. Bakri","doi":"10.1016/j.ajoint.2024.100017","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>To report displacement of thick submacular hemorrhage with pars plana vitrectomy (PPV) and subretinal tissue plasminogen activator (tPA) in a patient with Acute Myeloblastic Leukemia (AML).</p></div><div><h3>Design and Methods</h3><p>Case report.</p></div><div><h3>Results</h3><p>A 65-year-old man with a new diagnosis of AML developed significant intraretinal hemorrhages in both eyes; subretinal and sub-inner limiting membrane (ILM) hemorrhage in the left eye. He underwent 23-gauge PPV, subretinal tPA injection, and air-fluid exchange for subretinal hemorrhage. Foveal subretinal hemorrhage and visual acuity improved after surgery, but he had late post-operative vitreous hemorrhage.</p></div><div><h3>Observations</h3><p>A 65-year-old man with a new diagnosis of AML developed significant intraretinal hemorrhages in both eyes; subretinal and sub-inner limiting membrane (ILM) hemorrhage in the left eye. He underwent 23-gauge PPV, subretinal tPA injection, and air-fluid exchange for subretinal hemorrhage. Foveal subretinal hemorrhage and visual acuity improved after surgery, but he had late post-operative vitreous hemorrhage.</p></div><div><h3>Conclusions and Importance</h3><p>This novel case report documents successful displacing subretinal hemorrhage associated with AML with PPV and subretinal tPA.</p></div>","PeriodicalId":100071,"journal":{"name":"AJO International","volume":"1 2","pages":"Article 100017"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2950253524000170/pdfft?md5=7333898cc98382ae2dfbdf0817c54738&pid=1-s2.0-S2950253524000170-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJO International","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950253524000170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose

To report displacement of thick submacular hemorrhage with pars plana vitrectomy (PPV) and subretinal tissue plasminogen activator (tPA) in a patient with Acute Myeloblastic Leukemia (AML).

Design and Methods

Case report.

Results

A 65-year-old man with a new diagnosis of AML developed significant intraretinal hemorrhages in both eyes; subretinal and sub-inner limiting membrane (ILM) hemorrhage in the left eye. He underwent 23-gauge PPV, subretinal tPA injection, and air-fluid exchange for subretinal hemorrhage. Foveal subretinal hemorrhage and visual acuity improved after surgery, but he had late post-operative vitreous hemorrhage.

Observations

Conclusions and Importance

This novel case report documents successful displacing subretinal hemorrhage associated with AML with PPV and subretinal tPA.

查看原文本刊更多论文

急性髓细胞白血病相关视网膜下出血的手术移位

目的报告一名急性粒细胞白血病（AML）患者通过玻璃体旁切除术（PPV）和视网膜下组织纤溶酶原激活剂（tPA）治疗厚层玻璃体下出血的移位情况。他接受了 23 号 PPV、视网膜下 tPA 注射和视网膜下出血气液置换术。术后他的眼窝视网膜下出血和视力有所改善，但术后晚期出现玻璃体出血。他接受了 23 号 PPV、视网膜下 tPA 注射和视网膜下出血气液置换术。结论和重要性这篇新颖的病例报告记录了用PPV和视网膜下tPA成功置换与急性髓系白血病相关的视网膜下出血。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

AJO International

自引率

0.00%

发文量